Resident counselling for Smoking Cessation

University of California, San Francisco, San Francisco, CA
Targeting 2 different conditionsResident counselling +1 moreN/ARecruitingLed by Maya Vijayaraghavan, MD, MASResearch Sponsored by University of California, San Francisco

Study Summary

This trial will examine the impact of a smoke-free home intervention on reducing tobacco-caused disparities among 400 homeless residents in 20 sites across the San Francisco Bay Area.

Eligible Conditions
  • Smoking Cessation
  • Secondhand Smoke


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants who adopt a smoke-free home voluntarily
Secondary outcome measures
Proportion of participants who achieve abstinence

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Wait-List Control (Usual Care) then crossover to Smoke-free home PSH resident interventionExperimental Treatment1 Intervention
The current standard of care includes no interventions for smoke-free home adoption or referrals to smoking cessation resources. Wait-list group receives Smoke-Free Home (SFH) intervention after intervention group complete 6-month follow-up
Group II: Smoke-free home permanent supportive housing (PSH) resident intervention + Staff InterventionExperimental Treatment2 Interventions
Study staff will deliver a one hour, one-on-one counseling to PSH residents that includes: (1) a step-by-step guide on how to voluntarily adopt a smoke-free home, (2) information on second hand smoke (SHS) and third-hand smoke, alternative combustible tobacco and nicotine product use, cannabis-tobacco co-use, effects of SHS on kids and pets,(3) a worksheet on calculating personal costs related to tobacco use, and (4) pledges to designate one's home smoke-free. At follow-up assessments, the study team will ask participants whether they had a chance to view the intervention materials in between visits and will offer an opportunity for participants to discuss conflicts that they had experienced around smoke-free home adoption and will provide strategies to address these roadblocks.

Find a site

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,388 Previous Clinical Trials
12,257,853 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,369 Previous Clinical Trials
41,214,865 Total Patients Enrolled
Maya Vijayaraghavan, MD, MASPrincipal Investigator
University of California, San Francisco
1 Previous Clinical Trials
90 Total Patients Enrolled

Media Library

Resident counselling Clinical Trial Eligibility Overview. Trial Name: NCT04855357 — N/A
Smoking Cessation Research Study Groups: Smoke-free home permanent supportive housing (PSH) resident intervention + Staff Intervention, Wait-List Control (Usual Care) then crossover to Smoke-free home PSH resident intervention
Smoking Cessation Clinical Trial 2023: Resident counselling Highlights & Side Effects. Trial Name: NCT04855357 — N/A
Resident counselling 2023 Treatment Timeline for Medical Study. Trial Name: NCT04855357 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been recruited for this research project?

"Affirmative. The details available on confirm that this study is actively seeking participants, with the initial posting occuring on January 24 2022 and the most recent update being February 22nd 2022. 400 people need to be enrolled from 1 medical facility."

Answered by AI

Are opportunities for participation in this study still available?

"Affirmative. According to, enrollment is ongoing in this study which was first made public on January 24th 2022 and recently revised on February 22nd 2022."

Answered by AI
~133 spots leftby Jul 2024